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Abstract
Mutations in NIPBL are the major cause of Cornelia de Lange Syndrome (CdLS). NIPBL is the cohesin-loading factor and
has recently been associated with the BET (bromodomains and extra-terminal (ET) domain) proteins BRD2 and BRD4.
Related to this, a CdLS-like phenotype has been described associated to BRD4 mutations. Here, we show direct
interaction of NIPBL with different BET members in yeast, and selective interaction with BRD4 in cells, being the ET
domain involved in the interaction. To understand the relationship between NIPBL and BET proteins, we have
performed RNA-Seq expression analysis following depletion of the different proteins. Results indicate that genes
regulated by NIPBL largely overlap with those regulated by BRD4 but not with those regulated by BRD2. ChIP-Seq
analysis indicates preferential NIPBL occupancy at promoters, and knockdown experiments show mutual stabilization
of NIPBL and BRD4 on co-regulated promoters. Moreover, human fibroblasts from CdLS probands with mutations in
NIPBL show reduced BRD4 at co-occupied promoters. Functional analysis in vivo, using mutants of Drosophila
melanogaster, confirmed the genetic interaction between Nipped-B and fs(1)h, the orthologs of human NIPBL and
BRD4, respectively. Thus, we provide evidence for NIPBL and BRD4 cooperation in transcriptional regulation, which
should contribute to explain the recently observed CdLS-like phenotype associated with BRD4 mutations.
Introduction
Bromodomain and extra-terminal domain (BET) pro-
teins are chromatin readers with an important role in cell
cycle progression1–3. The BET family in vertebrates
comprises BRD2, BRD3, BRD4, and BRDt. With the
exception of the testis-specific member BRDt, BET pro-
teins are widely expressed during development and in the
adult. The observation that some BET members remain
associated to chromosomes during mitosis has led to
hypothesize that BET proteins act as true epigenetic fac-
tors marking key genes across generations4,5. Two tandem
bromodomains at the N-terminus are involved in recog-
nition of acetyl groups in proteins, notably histones6–9.
The prominent role that these proteins display in cell
cycle control has boosted the development of drugs
antagonizing BET proteins, as an effective therapy against
a variety of cancer types10,11. Thus, synthetic molecules
mimicking acetyllysine groups, which are able to effi-
ciently dissociate BET proteins from the chromatin, have
been successfully used for tumors treatment in mice12–17.
Besides the bromodomains, a conserved motif B (mB)
accounts for protein dimerization18, while the conserved
and exclusive extra-terminal (ET) domain involved in
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interaction with other proteins19 is distinctive of these
proteins and defines them as a family. In contrast to BRD2
and BRD3, BRD4 presents an additional C-terminal
domain (CTD) that is essential for its function20.
A preserved structure among the different BET proteins
and an elevated homology at the level of functional
domains, together with overlapping expression patterns
due to ubiquitous expression, have risen the question
about functional redundancy between members. How-
ever, Brd2 and Brd4, the most studied BET genes, appear
essential and nonredundant in vertebrates, considering
that single knockout mice were found to be embryonic
lethal21–23. In addition, while BRD4 exerts an important
role in transcription elongation as a component of the
transcription elongation complex P-TEFb24, BRD2 has
been mostly involved in transcription initiation2,25,26.
Finally, both proteins have been associated with the
Mediator complex and with different chromatin remo-
deling machineries19,27–29.
On the basis of different genomic occupancy, BRD2, but
not BRD4, was recently reported to associate with CTCF
and the cohesin complex to support cis-regulatory
enhancer assembly during transcription activation30.
Among cohesin complex proteins co-precipitating with
BRD2 is NIPBL, the cohesin-loading factor30. Hetero-
zygous mutations in NIPBL account for about 60% of the
cases of Cornelia de Lange syndrome (CdLS), a genetic
disorder with multiple abnormalities including growth
and mental retardation, inner organ malformations and a
typical facies31. Mutation of BRD4 was also recently
described to cause a CdLS-like phenotype, establishing a
link between NIPBL and BRD432. However, the molecular
mechanism behind these interactions remains unex-
plored. Therefore, at present, although a role in tran-
scription has been indicated for NIPBL33–36, the
relationship between BRD2 or BRD4 and CdLS is unclear.
From a two-hybrid screening previously performed18 we
identified NIPBL as a BRD2 partner. Here, we report
NIPBL interaction with different BET members in yeast.
However, immunoprecipitation (IP) experiments indicate
preferential association with BRD4 in mammal cells. To
establish functional association of NIPBL with BRD2 or
BRD4, we have compared cell transcriptomes following
knockdown of Nipbl, Brd2, or Brd4. Results reveal a
marked overlap in downregulated genes between cells
depleted of NIPBL and BRD4. Chromatin immunopreci-
pitation (ChIP) experiments in cell lines and primary
fibroblasts from CdLS patients with mutations in NIPBL
indicate mutual stabilization of both proteins at co-
regulated promoters, and analysis in Drosophila indicate
genetic interaction between NIPBL and BET coding
genes. Thus, our data strongly support a functional
cooperation between NIPBL and BRD4 in regulating gene
expression at the promoter level.
Results
NIPBL interacts with the ET domain of BET proteins
Searching for BRD2 partners, we previously performed a
two-hybrid screening by testing a truncated BRD2 bait
construct, which lacks the bromodomains, against an 11-
day-old mouse embryo cDNA library18. We identified up
to eight different proteins interacting with BRD2, being
the cohesin-loading factor NIPBL one of them. The
NIPBL interacting fragment that we isolated mapped to
the N-terminus (Fig. 1a). Two-hybrid indicated that the
interaction was not restricted to BRD2, since similar
constructs based on BRD3 and BRD4, also interacted with
NIPBL (Fig. 1b). Two-hybrid results also indicated
that BRD4 CTD was dispensable for NIPBL interaction
(Fig. 1b). Notably, mapping of the BET domain, which
mediates the interaction, revealed the involvement of
the ET domain rather than the region containing the mB
(Fig. 1b).
We next conducted IP experiments to analyze the
newfound interaction in the context of endogenous pro-
teins. For this purpose we precipitated NIPBL from
HEK293T cells extracts and analyzed co-precipitation of
BRD2 and BRD4. Interestingly we observed preferential
co-precipitation of BRD4 with NIPBL (Fig. 1c). The
opposite approach, i.e., precipitation of BET proteins and
analysis of co-precipitated NIPBL led to the same results
(Fig. 1c). We then analyzed co-precipitation of endogen-
ous NIPBL following precipitation of FLAG-tagged wild
type or truncated BRD4 (lacking the ET and CTD
domains; BRD4ΔC), which were expressed in
HEK293T cells. Results showed the absence of NIPBL
interaction when using the truncated BRD4ΔC protein
(Fig. 1d). Finally, interaction of N-terminal NIPBL with
BRD4 ET domain was assessed in an in vitro pull-down
experiment with purified proteins, which confirmed direct
interaction (Fig. 1e).
Thus, we have revealed a direct interaction of NIPBL
with BET proteins, and we have been able to define the
interaction surfaces. While the NIPBL interaction in the
yeast two-hybrid system was not restricted to a specific
BET member, preferential interaction with BRD4 was
observed in mammal cells.
Transcriptome analysis upon Nipbl, Brd2, and Brd4
knockdown reveals significant overlapping in genes
regulated by NIPBL and BRD4
Since NIPBL has been independently associated both
with BRD2 and with BRD4, we decided to compare the
transcriptome of cells depleted of NIPBL, BRD2, or BRD4
with the aim of identifying preferential functional BET
partners of NIPBL. For our analyses, we chose the P19
murine pluripotent embryonic carcinoma cell line
because such cells have been widely used in develop-
mental studies and are easy to manipulate and to
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transfect37. A commercially available and previously
validated esiRNA38 was used to knockdown Brd2, while
commercially available esiRNA and siRNA molecules
were used for Brd4 and Nipbl knockdown, respectively.
Then, the transcriptomes of the multiple knocked down
cells were analyzed in duplicate by RNA-Seq. We selected
mild-knockdown conditions (supplementary Fig. S1) to
mimic heterozygous mutations in CdLS. Principal com-
ponent analysis demonstrated strong similarity between
replicates and clearly separated different knockdown
samples (supplementary Fig. S2). Given our moderate
knockdown conditions we decided to take into account
Fig. 1 NIPBL interacts with BRD4 through the ET domain. a Schematic representation of the BET two-hybrid constructs used and the region of
NIPBL, as identified in the prey clone (amino acids 212–449), interacting with BET proteins. Numbers correspond to amino acid positions in the
mouse sequence. A graphic map of BRD4 with main domains is shown as a BET example. Relevant domains of NIPBL are also shown. BD1 and BD2
bromodomains 1 and 2, mB motif B, ET extra-terminal domain, CTD C-terminal domain, Q-rich glutamine rich domain. b The ß-galactosidase (ß-gal)
assay on yeast harboring the indicated prey and bait constructs. Blue color, interaction; white color, no interaction. c The immunoprecipitation assay
of endogenous NIPBL, BRD4, and BRD2 proteins analyzed by western blot after immunoprecipitation (IP) with NIPBL, BRD4, or BRD2 antibodies (α-) or
whole rabbit IgG. Input corresponds to 5% of the precipitated cell extract. d The immunoprecipitation assay to analyze by western blot co-
immunoprecipitated (co-IP) NIPBL with FLAG antibodies (α-FLAG) after transfection of FLAG-BRD4 (FL-B4) and FLAG-BRD4ΔC (FL-ΔC) expression
constructs. Inputs correspond to 5% of the precipitated cell extract. e The pull-down assay of E. coli-purified GST or a GST-ET fusion incubated with a
FLAG-tagged N-terminal NIPBL peptide. Retained and input (20%) NIPBL were revealed by western blot with FLAG antibodies, while input GST and
GST-ET (100%) were revealed by Coomassie blue staining
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changes in gene expression with a |Log2 (fold changes)| ≥
0.5. Thus, RNA-Seq analysis with this value and an
established p-value < 0.05 identified 770, 2739, and 945
genes differentially expressed upon Nipbl, Brd2, or Brd4
downregulation, respectively (Fig. 2, supplementary Table
S1). Interestingly, a strong overlap between the set of
genes misregulated upon Nipbl or Brd4 downregulation
was observed (5.9-fold enrichment for upregulated genes,
p= 3.35 × 10−19 and 6.2-fold enrichment for down-
regulated genes, p= 2.75 × 10−88) (Fig. 3a). In fact,
changes in gene expression upon Nipbl knockdown highly
correlated with changes in gene expression upon Brd4
knockdown (Pearson Correlation coefficient= 0.33, n=
12,000 active genes), but not with those observed upon
Brd2 knockdown (Pearson Correlation coefficient=
0.045, n= 12,000 active genes) (Fig. 3b). Two examples of
genes commonly downregulated after Brd4 or Nipbl
knockdown, but not upon Brd2 knockdown are shown in
Fig. 2b. Therefore, among NIPBL-dependent genes, a
significant set shows dependence on BRD4 but not on
BRD2. We did not observe alterations in Nipbl expression
when decreasing BRD4 protein (fold change= 1.002) or
vice versa (fold change= 0.997), indicating that the effects
of each knockdown are not due to changes in the
expression of its counterpart.
Gene ontology (GO) analysis indicated that NIPBL-
regulated genes shared more categories with BRD4-
regulated genes than with BRD2-regulated genes (sup-
plementary Fig. S3). Interestingly, GO analysis of com-
mon downregulated genes upon NIPBL or BRD4
depletion showed enrichment in categories such as ion
transport, central nervous system development, chon-
drocyte differentiation, regulation of ossification, hair
follicle development, axon guidance, and cell proliferation
(Fig. 3c), which are potentially related to many of the
observed traits of CdLS probands (i. e. psychomotor delay
and intellectual disability, craniofacial abnormalities,
skeletal deformations, hirsutism, and other developmental
alterations)31.
Out of this set of co-regulated genes, we selected 12 of
them (Adamts17, Ajap1, Chst1, Clstn2, Crybg1, Dner, Igf2,
Kcnc1, Kcnk3, Rasgef1b, Scml2, and Zbtb16)
Fig. 2 RNA-Seq analysis of P19 cells reveals changes in gene expression upon depletion of NIPBL, BRD2, or BRD4. a Volcano plots of
misregulated genes upon knocking down (KD) of the indicated genes. Established p-value and fold change (FC) cutoff is indicated by black-red
colors. Numbers inside plots indicate total number of misregulated genes and number of downregulated or upregulated genes. Genes selected for
validation are indicated in green. b Expression profiles of two genes in control and depleted cells, as indicated, were selected as examples. siC,
Control siRNA; esiB2, Brd2 esiRNA; esiB4, Brd4 esiRNA; siNip, Nipbl siRNA. Numbers in y-axis denote expression levels while numbers in x-axis indicate
genome positions
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representative of the indicated GO categories, for valida-
tion of the RNA-Seq results by quantitative PCR (qPCR)
(Fig. 2a, green dots in volcano plots). In each case, both
BRD4 and NIPBL depletion led to downregulation of gene
expression, while BRD2 depletion resulted in variable
effect with unaltered expression of most of the analyzed
genes (supplementary Fig. S4), confirming the RNA-Seq
data. Additional genes (Nog, Pim2, and T), not included in
the commonly regulated set, were also tested as controls.
As expected, qPCR analysis was in agreement with the
RNA-Seq data (supplementary Fig. S4). As the knock-
down of Brd4 and Nipbl was not previously assessed in
P19 cells, their transcriptional effect on such genes was
further confirmed using additional siRNA molecules
(supplementary Figs. S1 and S4).
Taken together, these data strongly indicate that BRD4
and NIPBL have a large number of common target genes,
which are related to biological processes potentially linked
to CdLS phenotype.
NIPBL and BRD4 stabilize each other at promoters of co-
regulated genes
Being NIPBL the most frequent CdLS causative gene, and
because it has not been clearly established if it preferentially
localizes at promoters or enhancers33,34,36,39, we decided to
conduct a ChIP-Seq analysis on P19 cells. We identified
7191 NIPBL peaks corresponding to 6490 genes. Of the
total number of peaks, 5615 mapped to promoter (TSS)
regions (Fig. 4a; supplementary Table S2), strongly asso-
ciating NIPBL to promoters rather than to enhancers.
Fig. 3 RNA-Seq analysis uncovers a high overlapping of misregulated genes upon NIPBL and BRD4 depletion. a Venn diagrams representing
overlapping of misregulated genes upon knocking down of the indicated genes. Numbers on the diagrams indicate the total number of
misregulated genes in each condition. Enrichment (enrich.) with the associated p-value between brackets, as determined by hypergeometric test, is
also indicated for the different comparisons. b Pearson correlation of altered gene expression after Nipbl knockdown, compared with Brd4 and Brd2
knockdowns. FC fold change. c Gene ontology (GO) analysis of commonly downregulated genes upon NIPBL and BRD4 depletion, showing different
categories of biological processes. n indicates the number of genes in the different categories
Luna-Peláez et al. Cell Death and Disease          (2019) 10:548 Page 5 of 14
Official journal of the Cell Death Differentiation Association
Among the 770 genes that were misregulated upon
Nipbl knockdown, 387 (50.3%) presented NIPBL peaks
(Fig. 4b) (1.7-fold enrichment, p= 3.3 × 10−33). Among
the 161 genes commonly downregulated when knocking
down Nipbl or Brd4, 91 (56.5%) presented NIPBL peaks at
the promoter region (1.9-fold enrichment, p= 1.6 ×
10−12) (Fig. 4b). We selected some of these genes (Fig. 4c)
to analyze NIPBL and BRD4 occupancy at promoters
following depletion of each protein. In order to assess the
importance of the NIPBL–BRD4 interaction in the con-
text of chromatin association and gene expression, we also
managed to analyze the effects of a truncated BRD4,
which lacks the C-terminal region containing the ET
domain interacting with NIPBL. As shown in Fig. 1d, the
BRD4ΔC construct proved unable to interact with NIPBL.
However, it is expected that it still binds to the chromatin
as it retains the bromodomains and the mB.
We first analyzed ChIP signal of NIPBL and BRD4
antibodies on the selected promoters in comparison with
normal rabbit IgG. As shown in Fig. 5a, results confirmed
the presence of the proteins at the selected promoters. We
also verified localization of the expressed FLAG-tagged
BRD4ΔC protein at these promoters by using FLAG
antibodies (Fig. 5b). This experiment confirmed our
Fig. 4 ChIP-Seq analysis shows major NIPBL localization at promoter regions. a Sectors diagram indicating the percentage of NIPBL peaks, as
determined through ChIP-Seq analysis, at transcription start sites (TSS) or out of TSS (no TSS). b Venn diagrams showing the number of genes with
NIPBL peaks overlapping either with genes regulated by NIPBL or with genes commonly downregulated upon NIPBL and BRD4 depletion, i.e., genes
dependent on both proteins. Numbers on the diagrams indicate the total number of genes in each condition. Percentage of overlapping genes,
referred to the total number of regulated genes in each analysis is also shown. c NIPBL localization on genes selected for further studies is shown.
y-axis denotes ChIP signal amplitude, while x-axis indicates genome positions
Luna-Peláez et al. Cell Death and Disease          (2019) 10:548 Page 6 of 14
Official journal of the Cell Death Differentiation Association
Fig. 5 NIPBL and BRD4 stabilize each other on the chromatin. a Localization of NIPBL and BRD4 at the promoters of the indicated genes was
assessed through ChIP analysis with the indicated antibodies (α-) in comparison with normal rabbit IgG. Relative ChIP levels are represented. b
Localization of BRD4ΔC at the promoters of the indicated genes was assessed through ChIP analysis with FLAG antibodies in comparison with normal
mouse IgG. FLAG signal was determined in cells transfected either with the expression construct for the BRD4ΔC protein as with empty vector.
Relative ChIP levels are represented. c NIPBL and BRD4 localization at the promoters of the indicated genes was assessed through ChIP analysis after
Nipbl or Brd4 knockdown (siNip#1, Nipbl siRNA #1, and siB4, Brd4 siRNA, respectively) in comparison with control conditions (siC, Control siRNA).
Relative ChIP levels are represented. d NIPBL and BRD4 localization at the promoters of the indicated genes was assessed through ChIP analysis after
transfection of the BRD4ΔC expression construct (B4ΔC) in comparison with control transfections with empty vector. Relative ChIP levels are
represented. e Schematic representation of the endogenous wild-type BRD4 and the expressed truncated BRD4ΔC protein, indicating the regions
recognized by the antibodies (α-) used for ChIP analysis. f Expression levels of the indicated genes, after transfection of the BRD4ΔC expression
construct were determined by qPCR. Relative levels of expression are represented. Cells transfected with empty vector were used as control. Values
are means ± s.d. from three independent experiments analyzed in triplicate. Statistical significance of differences between the different conditions
and IgG (a, b), control siRNA (siC) (c), or empty vector (d, f), is indicated on top of each bar. Statistical significance of differences between other
conditions is also indicated with a line. Significance was analyzed by Student’s t test (*p < 0.05, **p < 0.01, ***p < 0.001)
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prediction that binding of the truncated protein to the
chromatin is preserved. Then, we monitored the effect of
knocking down Nipbl or Brd4 on the localization of
endogenous NIPBL and BRD4 at promoters. Knockdown
experiments showed mutual dependence for chromatin
occupancy at selected promoters (Fig. 5c). Next, we ana-
lyzed the effect of expressing truncated BRD4. Expression
of BRD4ΔC was able to displace the endogenous BRD4
from the analyzed promoters (Fig. 5d). Since commercial
BRD4 antibodies were raised against the BRD4 CTD
domain, they only recognize the endogenous wild-type
protein and not truncated BRD4 (Fig. 5e). More impor-
tantly, the BRD4ΔC construct led to dissociation of
NIPBL from the chromatin (Fig. 5d). In addition, the
effects of truncated BRD4 on promoter localization of
endogenous BRD4 and NIPBL were accompanied by
altered expression of the corresponding genes (Fig. 5f).
Thus, our results indicate that NIPBL and
BRD4 stabilize each other on the chromatin in an
interaction-dependent manner, suggesting functional
cooperation of NIPBL and BRD4.
NIPBL–BRD4 interplay in human fibroblasts and Drosophila
melanogaster
We next analyzed additional models to study the relation
between NIPBL and BRD4. In this context, we decided to
assess whether BRD4 occupancy at NIPBL–BRD4 co-
regulated genes was altered also in human CdLS probands
carrying NIPBL mutations. To this end, we cultured fibro-
blasts from healthy and CdLS individuals40 and assessed
BRD4 occupancy at the selected promoters. We first
employed BRD4 antibodies on human samples relative to
normal rabbit IgG, revealing the presence of BRD4 at
selected promoters (Fig. 6a). Notably, ChIP experiments
also led us to confirm reduced occupancy of BRD4 at
promoters in human NIPBL-defective cells (Fig. 6b).
Finally, to evaluate in vivo the interaction between
NIPBL and BRD4, we exploited existing mutants of
Fig. 6 NIPBL–BRD4 relationship in different cellular models. a Localization of BRD4 at the promoters of the indicated genes was assessed in
human fibroblasts from Control2 healthy donor (see “Materials and methods”) through ChIP analysis with BRD4 antibody (α-BRD4) in comparison
with normal rabbit IgG. Relative ChIP levels for each gene were represented. Values are means ± s.d. from three independent experiments analyzed in
triplicate. b BRD4 localization at the promoters of the indicated genes was assessed through ChIP analysis in fibroblasts from two healthy donors
(Control2 and Control3) or from two CdLS probands with NIPBL mutations (CdLS1 and CdLS3). Relative ChIP levels for each gene were represented.
Values are means ± s.d. from two independent experiments analyzed in triplicate. c Quantification of the proportion of the different genotypes in the
female progeny from flies crosses between Nipped-B407 males and fs(1)h18 females. Values are means ± s.d. Data correspond to the analysis of 107
individuals from two independent experiments. d Expression levels of the indicated genes as determined in single heterozygous Nipped-B407 and fs(1)
h18 flies and in y w controls, were determined by qPCR. Relative levels of expression are represented. Statistical significance of differences between
the various conditions and IgG (a), control2 (b), or y w control (d) is indicated on top of each bar. Statistical significance of differences between other
conditions is indicated with a line. Significance was analyzed by Student’s t test (*p < 0.05, **p < 0.01, ***p < 0.001)
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Drosophila. In this organism, Nipped-B codes for NIPBL
while fs(1)h codes for a unique BET homolog. Upon
mating of fs(1)h18 and Nipped-B407 heterozygotes, we
scored the number of trans-heterozygous females in the
F1 progeny. Males hemizygous for fs(1)h18 die during
larval stages, thus trans-heterozygous F1 males could not
be reliably counted41. However, the observed percentage
of trans-heterozygous females was 17.8% (Fig. 6c),
revealing significant reduction from expected mendelian
inheritance (25%). We also analyzed expression of selec-
ted genes in single heterozygous Nipped-B407 and fs(1)h18
flies and in controls. Such analysis indicated that
expression of Shaw and Task7, respectively the Droso-
phila orthologs of Kcnc1 and Kcnk3, was also dependent
on both NIPBL and BET. Other genes such as SoxN, bsh,
and wg, the fly orthologs of Sox2, Nanog, and Wnt1, also
showed codependence on NIPBL and BET proteins, while,
as controls, arm and HDAC3, the orthologs of Ctnnb1
and Hdac8, were differently affected in the two mutant
lines (Fig. 6d).
Overall, our results establish a functional link between
NIPBL and BRD4, which is present in human fibroblasts
and D. melanogaster.
Discussion
In this work we report a novel interaction-mediated
cooperation between NIPBL and BRD4 to control tran-
scription of a large set of genes. Such cooperation is
supported by a number of findings: (i) NIPBL directly
interacts with BRD4 via its ET domain, (ii) transcriptome
analysis indicates that NIPBL and BRD4 regulate a com-
mon set of genes, (iii) ChIP experiments strongly suggest
that NIPBL and BRD4 co-localize and stabilize each other
at promoters of co-regulated genes, and (iv) a dominant
negative form of BRD4, which lacks the NIPBL interacting
domain and retains ability to bind the chromatin, is able
to displace endogenous BRD4 and NIPBL from promoters
with consequences in gene expression regulation.
Although co-precipitation of NIPBL and BRD4 has been
recently described32, direct interaction was not reported
so far, and the interacting domains were not known.
Concerning this, the ET domain represents an essential
domain for BET function, a finding supported by pre-
viously reported interactions19. Since the dominant
negative BRD4 molecule causes BRD4 and NIPBL to
detach from the chromatin and alters gene expression, the
NIPBL–BRD4 interaction seems relevant for cooperative
transcriptional control. We show that NIPBL interacts
with multiple BET proteins by yeast two-hybrid. Inter-
estingly, the interaction with BRD2 was not confirmed in
mammal cells. However, we cannot exclude NIPBL
association with different BET members depending on the
physiological conditions or cellular contexts. In this
regard, although some of the results obtained in P19 cells
have also been confirmed in human fibroblasts and in
Drosophila, it would be of interest to extend our studies to
additional cellular models.
Our RNA-Seq analyses indicate that NIPBL shares a
large number of common target genes with BRD4 but not
with BRD2, suggesting the possibility that NIPBL and
BRD4 cooperate in gene regulation. Despite this, NIPBL,
as part of the CTCF-cohesin complex, has been associated
with BRD2 in the context of enhancer assembly30. On the
other hand, BRD2 has also been associated with CTCF,
but not specifically with NIPBL, in the context of tran-
scription barriers along chromatin42. Animal models of
CdLS have revealed robust cohesion all along the chro-
mosomes and unaltered DNA replication, repair, and
chromosome segregation. However, models display local
impairment of cohesin loading on certain promoters,
which correlates with gene dysregulation, suggesting that
CdLS-associated phenotype derives from altered tran-
scription rather than from defective chromosomal cohe-
sion processes35. Moreover, an important role of NIPBL
in chromatin architecture and transcription has been
decoupled from cohesin and CTCF36,43. Besides this, it
has been well reported that removal of cohesin does not
cause major changes in gene expression44–46. Thus, it is
plausible that NIPBL displays general structural and
architectural roles on the chromatin as a component of
the cohesin complex, also involving BRD2, but a tighter
relation is established with BRD4 for specific control of
gene expression. In relation to this, our GO analysis
showed enrichment in a number of categories related with
many of the observed traits in CdLS probands31, a finding
that might help explain the recent observation of CdLS-
like defects in individuals carrying mutations in BRD432.
Our ChIP-Seq data reveal preferential association of
NIPBL with promoters, while BRD4 has been localized at
both promoters and enhancers, with a relevant role in
superenhancers13,47–50. NIPBL localization at promoters
has been previously reported36,51. Considering this, it
would be of interest to address whether interaction
between enhancer-associated BRD4 and promoter-
associated NIPBL might participate in
promoter–enhancer assembly. Provided that most com-
mon misregulated genes under knockdown conditions are
related to important developmental processes, these
hypothetical promoter–enhancer contacts acquire special
importance at relevant developmental regulated enhan-
cers. Thus, major localization of NIPBL at promoters does
not exclude enhancer-mediated roles of NIPBL, due in
part to putative enhancer–promoter contacts but also to
direct localization of NIPBL at certain enhancers.
Our analysis also reveals that a significant proportion of
NIPBL bound genes appear unaffected by NIPBL knock-
down or fall out of the set of commonly regulated genes.
Although our moderate knockdown conditions may have
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excluded a number of genes from the set of affected genes,
it is also possible that NIPBL location at some regions is
unrelated to gene expression, but is related, for example,
to its cohesin-loading role. In this sense we have pre-
viously mentioned the reported absence of major tran-
scriptional changes upon removal of cohesin44–46. We
also assume the concurrence of indirect effects on gene
expression by NIPBL depletion and regulation of parti-
cular genes by NIPBL independently of BRD4.
ChIP experiments indicate that NIPBL and BRD4
mutually stabilize on the chromatin. We show such
phenomenon in both mouse and human cells. The effect
of truncated BRD4 as a dominant negative molecule able
to displace both endogenous BRD4 and NIPBL from the
chromatin strongly supports this idea. Mutual stabiliza-
tion of NIPBL and BRD4 on the chromatin prompts the
question of whether these proteins form a complex before
chromatin binding or whether one of them is previously
recruited to the chromatin priming the association to its
partner. In this context, it is tempting to speculate that
BRD4, which is able to recognize acetylated histones,
could initially associate to the chromatin to subsequently
recruit NIPBL. However, Olley et al.32 describe that more
typical CdLS was observed with a de novo missense
mutation in the 2nd bromodomain of BRD4 altering its
chromatin binding capacity but not the ability to interact
with NIPBL, which is in agreement with our observation
of the ET domain mediating the interaction. This suggests
that in patients with this BRD4 mutation, a complex with
NIPBL is formed, but according to our results, unable to
stabilize at the chromatin. Further research on this matter
will clarify on sequential mechanisms involved in the
cooperative action of both proteins.
Finally, the analysis of Drosophila as an animal model
revealed the existence of a genetic interaction between
Nipped-B and fs(1)h, the fly genes coding for NIPBL and
the only BET protein, which is based on altered mendelian
ratios. While this manuscript was in preparation, using a
different fs(1)h mutant allele, Pherson et al.51 also repor-
ted genetic interaction of Nipped-B and fs(1)h in Droso-
phila in the context of cohesin occupancy of origin of
replication chromatin, supporting our results. Gene
expression analysis of selected genes in single mutants
also confirmed co-regulation in Drosophila. Of special
interest were Shaw and Task7, the orthologs of Kcnc1 and
Kcnk3, which were downregulated in both single mutants.
In addition, wg, the ortholog of mouse Wnt1, also showed
altered expression in both single mutants, in agreement
with previously reported wnt1 misregulation in zebrafish
after nipblb downregulation40.
In conclusion, we provide evidence for direct interac-
tion and cooperation of NIPBL and BRD4 to control gene
expression, which could be relevant to CdLS-like traits of
probands with mutations in the corresponding genes31,32.
In particular, our study establishes for the first time a
functional basis for the association of these proteins.
Further investigation of such interaction will provide a
detailed molecular description of gene expression in an
important rare human disease.
Materials and methods
Yeast two-hybrid
Yeast manipulation and ß-galactosidase assays for yeast
two-hybrid experiments were performed with the
DUALhybrid Kit (DualSystems Biotech, Schlieren, Zurich,
Switzerland) using the pLexA-N bait and pGAD-HA prey
vectors, according to the manufacturer instructions and as
previously described18. pLexA-BRD2, pLexA-BRD3,
pLexA-BRD4, pLexA-mB, and pLexA-ET constructs were
described previously18,38.
Plasmid constructs and siRNA molecules
Expression construct for full-length mouse Brd4 has been
previously described18 and was based on pAdRSV-Sp vector
with an N-terminal FLAG tag. Deletion of the C-terminal
half of BRD4 (amino acids 603–1400) in the BRD4ΔC
construct was generated by standard PCR techniques. GST-
ET and GST-FLAG-NIPBL, generated by standard PCR
techniques, were based on pGEX-6P-3 vector (GE Health-
care, Buckinghamshire, UK) and containing amino acids
609–718 of BRD4 and 212 to 449 of NIPBL, respectively.
The siRNA molecules used for the different knockdowns
were all obtained from Sigma-Aldrich (St. Louis, MO, USA),
and are as follows: Nipbl siRNA #1, GCGAUAUACC
CGUCUUGUU (SASI_Mm02_00351489); Nipbl siRNA #2,
GGAAGAUUGGUAGCUUGUA (SASI_Mm02_00351487);
Brd4 siRNA, GAGAAGGACAAGAAGGAAA; Control
siRNA, CGUACGCGGAAUACUUCGA; Brd4 esiRNA,
MISSION esiRNA EMU051511; Brd2 esiRNA, MISSION
esiRNA EMU067621; Control esiRNA, MISSION esiRNA
EHUFLUC. Control siRNA and esiRNA correspond to the
Luciferase gene.
Cell culture and transfection
Human HEK293T cells were cultured in Dulbecco’s
Modified Eagle’s Medium (Sigma-Aldrich) supplemented
with 10% fetal bovine serum (Sigma-Aldrich). This line
was used for IP experiments. Mouse P19 cells were
directly purchased from ATCC (LGC Standards, Barce-
lona, Spain) as authenticated and were cultured in α-
modified Minimum Essential Medium (HyClone, Logan,
UT, USA) supplemented with 7.5% calf serum (HyClone)
and 2.5% fetal bovine serum. Transfections were per-
formed with Lipofectamine 2000 or Lipofectamine
RNAiMax (Invitrogen, Life Technologies, Paisley, UK) for
plasmids (24 h) and siRNAs (72 h), respectively.
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Human fibroblasts
Human fibroblasts were raised from biopsies from two
CdLS patients with known mutation in NIPBL and
two age-matched healthy controls described by Pistocchi
et al. 40. Patients with CdLS, assessed with severe mental
retardation, correspond to CdLS1 and CdLS3 individuals
described by Pistocchi et al.40. Healthy donors, one male
and one female Italian pediatric patients, were undergoing
surgical procedures for dermatological testing, and cor-
respond to Control2 and Control3 described by Pistocchi
et al.40. Fibroblasts were cultured in RPMI medium sup-
plemented with 10% FBS, and samples from the same
passage (p2) were used. Experiments conformed to the
principles set out in the WMA Declaration of Helsinki
and in the Belmont Report.
D. melanogaster culture
Flies were maintained on cornmeal, yeast, and agar/
molasses medium at 25 °C according to standard proto-
cols. We used lines with the fs(1)h18 mutant allele
(Bloomington Stock #5285: fs(1)h18/FM7c) and the
Nipped-B407 allele (y w; Nipped-B407 P{w+}57B/CyO, Kr-
GFP)52, a loss of function allele. Drosophila Nipped-B
mutants are recognized as a model of CdLS (Flybase:
FBhh0000605). In all experiments, mutant and control
flies were grown at the same time with the same batch of
food preparation. Two biological repetitions of the
experiment were performed in triplicate. The cross to
evaluate interaction between fs(1)h and nipped-B was
done using the following genotypes: ten virgin females (fs
(1)h18/FM7c) and five males (y w; Nipped-B407 P{w+}
57B/CyO, Kr-GFP). The different genotypes were col-
lected looking at the different flies’ phenotypes. Flies
carrying fs(1)h18 allele did not display bar eyes; while flies
carrying Nipped-B407 allele did not display curly wings.
Protein IP, immunoblotting, purification, and in vitro pull-
down
For IP, cells were extracted with buffer [150 mM NaCl,
50 mM Tris-HCl pH 7.5, 2.5 mM Mg+2, 1% Triton X-100,
and complete protease inhibitor cocktail w/o EDTA
(Roche, Mannheim, Germany)] and incubated for 1 h at
37 °C with Bit-nuclease (bimake.com, Munich, Germany).
Concentration was determined by the Bradford reactive
assay (Bio-Rad, Hercules, CA, USA) and 1mg of protein
was incubated overnight at 4 °C in rotation with FLAG-
beads (Sigma-Aldrich) or the corresponding antibody.
Antibodies were precipitated after 2 h of incubation at
4 °C in rotation with protein A Dynabeads (ThermoFisher
Scientific, Waltham, MA, USA). After washing, proteins
were eluted from beads with 20 µL of Laemmli buffer and
10min of boiling before the analysis by immunoblotting.
For this, eluted proteins or whole extracts (25 µg of pro-
tein) were separated in an SDS gel and subsequently
transferred to a PVDF membrane (GE Healthcare) and
blotted with antibodies. The membrane was processed
with a chemiluminescence ECL system (Bio-Rad) and
monitored in a ChemidDoc XRS apparatus (BioRad). The
antibodies used were: mouse anti-FLAG M2 (1:2000,
Sigma-Aldrich), mouse anti-α-TUBULIN (1:5000, Sigma-
Aldrich), rabbit anti-NIPBL (1:3000, A301-779A, Bethyl
Laboratories, Inc., Montgomery, TX, USA), rabbit anti-
BRD4 (1:2000, A301-985A100, Bethyl Laboratories, Inc.)
rabbit anti-BRD218 (1:1000) and horseradish peroxidase
(HRP)-conjugated goat anti-mouse IgG and goat anti-
rabbit IgG (1:10000, Sigma-Aldrich). Normal rabbit IgG
(Sigma-Aldrich) was used as a negative control. GST,
GST-ET, and GST-FLAG-NIPBL proteins were produced
in Escherichia coli DH5α and purified on Glutathione
Sepharose beads (GE Healthcare). While GST and GST-
ET proteins were kept bound to beads, FLAG-NIPBL was
excised from GST by using the PreScission Protease (GE
Healthcare) according to manufacturer’s instructions. In
vitro pull-down assays were performed as previously
described53.
RNA extraction, quantitative real-time PCR (qPCR), and
RNA-Seq
Total RNA was extracted from P19 cells using the NZY
Total RNA isolation kit (NZYTech, Lisbon, Portugal) and
was retro-transcribed using the iScript cDNA Synthesis
kit (BioRad). qPCR was performed with Power SYBR
Green (Applied Biosystems, Carlsbad, CA, USA) in the
ViiA7 Real-Time PCR System (Applied Biosystems). The
RpLp0 gene was used as a reference gene to analyse
relative expression. For analysis of gene expression in D.
melanogaster, total RNA was extracted from whole ani-
mals of each of the three genotypes (n= 15) using the
RNeasy mini kit (Qiagen). Two micrograms of RNA was
retro-transcribed using the SuperScript™ VILO™ cDNA
Synthesis Kit (Invitrogen) and qPCR was performed with
SsoFast™ EvaGreen® Supermix (BioRad) using the CFX96™
Real-Time PCR Detection Systems (BioRad). Amplifica-
tion of RpL32 transcripts was used as a normalizer.
Normalization was done according to ref. 54. The primers
used are detailed in supplementary Table S3. For RNA-
Seq, total RNA was extracted using the RNeasy kit
(QIAGEN, Austin, TX, USA) and analyzed in CABIMER
Genomics facility. The libraries were prepared with the
TruSeq Stranded TOTAL RNA kit (Illumina, San Diego,
CA, USA) and the sequencing was performed with the
NextSeq500 HIGH-Output and 1x75bp length para-
meters. RNA-Seq data were primarily filtered using the
FASTQ Toolkit v1.0.0 program. Data were aligned using
Subjunc function from Rsubread55 v.1.28.1 bioconductor
package, to map reads to the mm9 mouse reference
genome, using TH1= 2 and unique=TRUE parameters.
The downstream analysis was performed on bam files
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with duplicates removed using the samtools56 v.0.1.19
rmdup command. FeatureCounts() function from Rsu-
bread v.1.28.1 bioconductor package was used to assign
reads to UCSC mm9 genes using GTF.featureType
= “exon” and GTF.attrType= “gene_id” parameters on
duplicate removed bam files. Then differential gene
expression analysis was performed using the voom/
limma57 v.3.34.9 and edgeR58,59 v.3.20.9 bioconductor
packages. Genes that were expressed at >1 counts per
million mapped reads in ≥2 replicates were analyzed.
CalcNormFactors() function using TMM method was
used to normalize samples. For each comparison
(siNipbl#1 vs siControl, esiBrd4 vs siControl, and esiBrd2
vs siControl), we selected those genes that were upregu-
lated or downregulated with a p-value < 0.05 and
|log2(FC)| ≥ 0.5. Data have been deposited under acces-
sion number GEO: GSE132785.
ChIP and ChIP-Seq
Cells were crosslinked in 1% formaldehyde for 10min at
room temperature followed by addition of glycine
(125 mM as final concentration) for 5 min. Nuclei were
isolated using lysis buffer 1 [5 mM Pipes pH 8, 85 mM
KCl, 0.5% NP40, and complete protease inhibitor cocktail
(Roche)] and were lysed using lysis buffer 2 [1% SDS,
10 mM EDTA, 50mM Tris-HCl pH 8.1, and complete
protease inhibitor cocktail (Roche)]. Chromatin was
sheared into an average size of 500 bp by 8 or 20, 30 s
pulses (30 s pause between pulses) for P19 cells and
human fibroblasts, respectively at 4 °C in the water bath
sonicator Bioruptor (Diagenode, Liège, Belgium). Thirty
or eight micrograms of chromatin from P19 cells or
human fibroblasts, respectively, was incubated overnight
at 4 °C in rotation diluted 1:10 in IP buffer [0.01% SDS,
1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH
8.1, and 167 mM NaCl] and with the respective antibodies
[3 µg of anti-BRD4 (A301-985A100, Bethyl Laboratories,
Inc.), 3 µg of anti-NIPBL (A301-779A, Bethyl Labora-
tories, Inc.), 3 µg of anti-FLAG M2 (Sigma-Aldrich), or
3 µg normal rabbit or mouse IgG (Sigma-Aldrich) as
negative controls]. IPs were incubated for 2 h at 4 °C in
rotation with protein A or G Dynabeads (Invitrogen) for
rabbit or mouse antibodies, respectively, and then washed
with wash buffer 1 (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20mM Tris-HCl pH 8.1, and 150mM NaCl),
wash buffer 2 (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20mM Tris-HCl pH 8.1, and 500mM NaCl), wash buffer
3 (0.25M LiCl, 1% NP40, 1% sodium deoxycholate, 1 mM
EDTA, and 10 mM Tris-HCl pH 8.1), and twice with TE
buffer (10 mM Tris-HCl pH 8.0 and 1mM EDTA). The
complexes were eluted from the beads with elution buffer
(1% SDS in TE buffer) by incubating twice 10min at
65 °C. The eluates and the inputs (3 or 1 µg of chromatin
from P19 cells or human fibroblasts, respectively) were
incubated overnight at 65 °C for de-crosslinking. All the
samples were treated with proteinase K (Roche) for 1 h at
37 °C and purified using the ChIP DNA Clean & Con-
centrator kit (Zymo Research, Irvine, CA, USA). ChIP-
qPCR was performed with Power SYBR Green (Applied
Biosystems) in the ViiA7 Real-Time PCR System (Applied
Biosystems). The primers used are detailed in supple-
mentary Table S3. ChIP-Seq was performed in GENE-
CORE (EMBL Genomics Core Facility). The ChIP-Seq
reads were aligned using align function from Rsubread55
v.1.28.1 bioconductor package, to map reads to the mm9
mouse reference genome, using TH1= 2 and unique=
TRUE parameters. The downstream analysis was per-
formed on bam files with duplicates removed using the
samtools56 v.0.1.19 rmdup command. MACS260 version
2.1.1 was used to call NIPBL narrow peaks against input
with a cutoff of −log10(q-value)= 15 and mfold= 5. To
assess the overlapping between NIPBL peaks and TSS first
we defined TSS as 2 kb windows (1 kb upstream and 1 kb
downstream) for the TSS of all UCSC mm9 genes
(knownGene), then bedtools61 v2.27.1 subtract command
was used to determine those NIPBL peaks which overlap
to TSS or not. AnnotatePeakInBatch() function from
ChIPPeakAnno62 v3.10.1 bioconductor package was used
to annotate peaks to UCSC mm9 genes. Data have been
deposited under accession number GEO: GSE132784.
Statistical analysis and additional tools
Statistical analyses were performed with the Prism 5.0a
software (GraphPad). Data were generated from several
repeats of different biological replicates. Mean values ± s.d.
were represented in the different graphs. Except when
indicated, data correspond to three independent experi-
ments analyzed in triplicate. To determine significance of
differences between conditions Student’s t tests for
unpaired samples with confidence interval of 95% were
computed. Significance between conditions were indi-
cated with the symbols *p < 0.05, **p < 0.01, ***p < 0.001.
Regression plots and determination of Pearson coeffi-
cients and p-value were performed using the Prism 5.0a
software (GraphPad). To test the significance of over-
lapping in Venn diagrams, hypergeometric tests were
performed in R, using the dhyper function from the Stats
package. Venn diagrams were performed in Venny 2.1
(http://bioinfogp.cnb.csic.es/tools/venny/index.html). GO
functional categories were analyzed using DAVID63.
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